BRPI0711967A2 - ensaio de biomarcador de espectrometria de massa - Google Patents

ensaio de biomarcador de espectrometria de massa Download PDF

Info

Publication number
BRPI0711967A2
BRPI0711967A2 BRPI0711967-4A BRPI0711967A BRPI0711967A2 BR PI0711967 A2 BRPI0711967 A2 BR PI0711967A2 BR PI0711967 A BRPI0711967 A BR PI0711967A BR PI0711967 A2 BRPI0711967 A2 BR PI0711967A2
Authority
BR
Brazil
Prior art keywords
biomarker
sample
signal
mass
biomarkers
Prior art date
Application number
BRPI0711967-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Toshihide Nishimura
Atsushi Ogiwara
Takeshi Kawamura
Takao Kawakami
Yutaka Kyono
Mitsuhiro Kanazawa
Fredrik Nyberg
Gyoergy Marko-Varga
Hisase Anyoji
Original Assignee
Astrazeneca Uk Ltd
Medical Proteoscope Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd, Medical Proteoscope Co Ltd filed Critical Astrazeneca Uk Ltd
Publication of BRPI0711967A2 publication Critical patent/BRPI0711967A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/74Optical detectors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers
    • G01N30/7233Mass spectrometers interfaced to liquid or supercritical fluid chromatograph

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
BRPI0711967-4A 2006-06-13 2007-06-13 ensaio de biomarcador de espectrometria de massa BRPI0711967A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0611669.3A GB0611669D0 (en) 2006-06-13 2006-06-13 Mass spectrometry biomarker assay
GB0611669.3 2006-06-13
PCT/GB2007/002187 WO2007144606A2 (en) 2006-06-13 2007-06-13 Mass spectrometry biomarker assay

Publications (1)

Publication Number Publication Date
BRPI0711967A2 true BRPI0711967A2 (pt) 2012-01-24

Family

ID=36745797

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0711967-4A BRPI0711967A2 (pt) 2006-06-13 2007-06-13 ensaio de biomarcador de espectrometria de massa

Country Status (10)

Country Link
EP (1) EP2035829A2 (es)
JP (1) JP2009540319A (es)
KR (1) KR20090068199A (es)
CN (1) CN101611313A (es)
AU (1) AU2007258970A1 (es)
BR (1) BRPI0711967A2 (es)
CA (1) CA2651934A1 (es)
GB (1) GB0611669D0 (es)
MX (1) MX2008015158A (es)
WO (1) WO2007144606A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011528790A (ja) * 2008-07-23 2011-11-24 ピー デバイシズ インコーポレーテッド プラズマを利用する携帯型診断装置及び診断方法
GB0906698D0 (en) 2009-04-17 2009-06-03 Queen Mary & Westfield College Method for quantifying modified peptides
KR101144237B1 (ko) * 2009-12-29 2012-05-11 한국기초과학지원연구원 고분해능 질량분석법과 약리활성검사를 이용한 천연물의 약리 활성물질 발굴 방법
GB201006360D0 (en) * 2010-04-16 2010-06-02 Immatics Biotechnologies Gmbh Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
US9141756B1 (en) 2010-07-20 2015-09-22 University Of Southern California Multi-scale complex systems transdisciplinary analysis of response to therapy
CN102201039A (zh) * 2010-08-19 2011-09-28 上海聚类生物科技有限公司 一种分析ltq数据的方法
GB201204278D0 (en) 2012-03-09 2012-04-25 Queen Mary & Westfield College Method
FR3016461B1 (fr) * 2014-01-10 2017-06-23 Imabiotech Procede de traitement de donnees d'imagerie moleculaire et serveur de donnees correspondant
DE102014000646B4 (de) 2014-01-17 2023-05-11 Bruker Daltonics GmbH & Co. KG Massenspektrometrische Resistenzbestimmung durch Metabolismus-Messung
GB201509313D0 (en) * 2015-05-29 2015-07-15 Micromass Ltd Sample mass spectrum analysis
JP6613490B2 (ja) * 2016-02-19 2019-12-04 国立大学法人 宮崎大学 腺癌の検出方法
MA44511A (fr) * 2016-03-31 2019-02-06 Discerndx Inc Génération et utilisation de bases de données de biomarqueurs
PL3465222T3 (pl) 2016-05-24 2021-09-27 In Ovo Holding B.V. Sposób i układ nieniszczącego określania płci ptactwa drobiu in ovo
AU2017314217A1 (en) * 2016-08-19 2019-03-28 Monash University Spectroscopic systems and methods for the identification and quantification of pathogens
US9905405B1 (en) * 2017-02-13 2018-02-27 Thermo Finnigan Llc Method of generating an inclusion list for targeted mass spectrometric analysis
EP3646328A4 (en) * 2017-06-29 2021-04-21 Quanticision Diagnostics Inc. APPARATUS AND METHOD FOR ABSOLUTE QUANTIFICATION OF BIOMARKERS ALLOWING A DIAGNOSIS OF SOLID TUMOR
MY202410A (en) 2017-09-01 2024-04-27 Venn Biosciences Corp Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
CN111316106A (zh) * 2017-09-05 2020-06-19 迪森德克斯公司 自动化样品工作流程门控和数据分析
GB2569805B (en) * 2017-12-22 2023-03-08 Asymptote Ltd Method and system relating to cooling conditions for a biological sample
EP3794548B1 (en) * 2018-05-15 2024-06-26 Ventana Medical Systems, Inc. Quantitation of signal in stain aggregates
CN111672658B (zh) * 2020-06-08 2022-05-13 惠州市新泓威科技有限公司 电子雾化设备最佳雾化温度的检测与控制方法及其电子雾化设备
EP4047371A1 (en) * 2021-02-18 2022-08-24 Thermo Fisher Scientific (Bremen) GmbH Method and apparatus for analysing samples of biomolecules using mass spectrometry with data-independent acquisition
KR102632163B1 (ko) 2022-04-13 2024-02-01 오보젠 주식회사 가금류 알(卵)의 암수 검사 및 선별장치 그리고 이를 이용한 선별방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004061410A2 (en) * 2002-12-18 2004-07-22 Ciphergen Biosystems, Inc. Serum biomarkers in lung cancer
DE10324149A1 (de) * 2003-05-26 2004-12-16 Imat-Uve Gmbh Verfahren und Vorrichtung zur GC/MS- oder LC/MS-Screeninganalyse
AU2005231101A1 (en) * 2004-03-30 2005-10-20 Eastern Virginia Medical School Lung cancer biomarkers
GB2430794B (en) * 2004-05-20 2009-10-21 Waters Investments Ltd Method and apparatus for identifying proteins in mixtures

Also Published As

Publication number Publication date
EP2035829A2 (en) 2009-03-18
CA2651934A1 (en) 2007-12-21
CN101611313A (zh) 2009-12-23
MX2008015158A (es) 2009-04-30
AU2007258970A1 (en) 2007-12-21
WO2007144606A3 (en) 2008-04-03
KR20090068199A (ko) 2009-06-25
JP2009540319A (ja) 2009-11-19
GB0611669D0 (en) 2006-07-19
WO2007144606A2 (en) 2007-12-21

Similar Documents

Publication Publication Date Title
BRPI0711967A2 (pt) ensaio de biomarcador de espectrometria de massa
Issaq et al. Peer reviewed: SELDI-TOF MS for diagnostic proteomics
Veenstra Global and targeted quantitative proteomics for biomarker discovery
Domon et al. Options and considerations when selecting a quantitative proteomics strategy
Baker et al. Mass spectrometry for translational proteomics: progress and clinical implications
US20060031023A1 (en) Mass intensity profiling system and uses thereof
Bowler et al. Proteomics in pulmonary medicine
WO2002097703A2 (en) Method to identify constituent proteins by peptides profiling
AU2015237804A1 (en) Means and methods for determination of quality of blood samples based on metabolite panel
Sokolowska et al. Applications of mass spectrometry in proteomics
JP4051400B2 (ja) プロテオーム網羅的解析における特異的蛋白質のスクリーニング方法
Bjerrum Metabonomics: analytical techniques and associated chemometrics at a glance
Merkley et al. A proteomics tutorial
WO2005057208A1 (en) Methods of identifying peptides and proteins
Vaezzadeh et al. Proteomics and opportunities for clinical translation in urological disease
WO2008022266A2 (en) Methods and systems for quantifying isobaric labels and peptides
Mena et al. Next generation instruments and methods for proteomics
Wang et al. SWATH-MS in proteomics: current status
Henry et al. Introduction to sample preparation for proteomics and mass spectrometry
Hewel et al. High‐resolution biomarker discovery: Moving from large‐scale proteome profiling to quantitative validation of lead candidates
Wang Introduction to proteomics for chemical biology
Petrák Proteomics and its role in medicine
JPWO2007072648A1 (ja) 質量分析システムおよび質量分析方法
WO2007023876A1 (ja) 多数試料中に含まれる物質の存在量を比較解析する方法
ÜNAL Mass Spectrometry in Clinical Diagnosis: Cancer Biomarkers

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 4A E 5A ANUIDADES.